Clinical Trial Update: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update involving aspirin for Dukes C and high-risk Dukes B colorectal cancer; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN